期刊簡介 | |||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
期刊名稱 | Acta Cardiologica Sinica LetPub Score 3.8
50 ratings
Rate
Reputation 4.2 Influence 2.4 Speed 9.1 | ||||||||||||||||
期刊簡稱 | ACTA CARDIOL SIN | ||||||||||||||||
ISSN | 1011-6842 | ||||||||||||||||
h-index | 12 | ||||||||||||||||
CiteScore |
| ||||||||||||||||
自引率 (2023-2024) | 22.20%自引率趨勢 | ||||||||||||||||
掲載範囲 |
| ||||||||||||||||
官方網站 | http://www.tsoc.org.tw/index.php?action=journal | ||||||||||||||||
在線稿件提交 | http://www.tsoc.org.tw/index.php?action=journal&do=page&cid=1&id=58 | ||||||||||||||||
開放訪問 | No | ||||||||||||||||
出版商 | Republic of China Society of Cardiology | ||||||||||||||||
主題領域 | 医学 | ||||||||||||||||
出版國/地區 | TAIWAN | ||||||||||||||||
發行頻率 | 四半期刊行 | ||||||||||||||||
創刊年 | 1985 | ||||||||||||||||
每年文章數 | 60每年文章數趨勢 | ||||||||||||||||
黃金OA百分比 | 0.00% | ||||||||||||||||
Web of Science 四分位 ( 2023-2024) | WOS Quartile: Q3
| ||||||||||||||||
索引 (SCI or SCIE) | Science Citation Index Expanded | ||||||||||||||||
鏈接到PubMed Central (PMC) | https://www.ncbi.nlm.nih.gov/nlmcatalog?term=1011-6842%5BISSN%5D | ||||||||||||||||
平均審稿時間 * | 來自出版商的數據: 來自作者的數據: >12 Week(s), or Invited contributions | ||||||||||||||||
競爭力 * | 來自作者的數據: Easy | ||||||||||||||||
參考鏈接 |
| ||||||||||||||||
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。 |
|
|
首頁 上一頁 1 下一頁 末頁 (頁 | |
[Acta Cardiologica Sinica] 的評論 | 撰寫評論 |
作者: 维尔娜菲茨杰拉德 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-30 18:26:59 評論於 This varies from person to person. If the main result has been completed, it is generally recommended to start with the results. If the main result is still in progress, you can start with the methods and introduction(0) 讚! | 维尔娜菲茨杰拉德 |
作者: 维尔娜菲茨杰拉德 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-30 09:30:01 評論於 It is recommended to complete the main results section before starting to write the article. You can also start brainstorming the article after obtaining the main phenotype data or designing the topic, and start writing while doing it(0) 讚! | 维尔娜菲茨杰拉德 |
作者: 深渊兴业 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-28 10:24:26 評論於 What is the general writing order of a research article?(0) 讚! | 深渊兴业 |
作者: 破戒阳平 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-26 16:19:44 評論於 At what stage of the experiment is it more appropriate to start writing?(0) 讚! | 破戒阳平 |
作者: 天际士航 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2020-12-25 16:41:31 評論於 I have also been awaiting EIC decision for a long time, how about your result?(0) 讚! | 天际士航 |
作者: 虚徒丰雅 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2020-06-08 12:32:34 評論於 It has been 20 days since my awaiting EIC decision, I wonder if it is good or bad luck ?(0) 讚! | 虚徒丰雅 |
作者: 墟散诗雯 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2020-05-03 12:13:56 評論於 Today I received email confirmations from each author, so I should be able to proceed, right? Thank you(0) 讚! | 墟散诗雯 |
作者: 墟散诗雯 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2020-04-30 09:52:49 評論於 Does this magazine charge for placement?(0) 讚! | 墟散诗雯 |
作者: 墟散诗雯 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2019-09-30 10:32:51 評論於 My submission has always been in the state of "View Submission," what's going on?(0) 讚! | 墟散诗雯 |
作者: 不灭和宜 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2019-04-11 16:11:21 評論於 Review Speed: 2.0 | Acceptance Rate: 50.0 Experience Sharing: The review process was relatively long. The submission was made on October 29, 2018, and the first review was completed on January 2, 2019. A major revision was requested on January 10, with the second review completed on March 10. Minor revisions were requested on March 11, and acceptance was on March 27. Overall, the submission process was quite smooth, the editor was very nice, and the review comments were also very fair(0) 讚! | 不灭和宜 |
作者: asdgh 領域: 医学 審稿時間: 3.0 month(s) 結果: 修改後接受 撰寫評論 |
2018-09-26 16:51:39 評論於 Very good journal.You can try to contribute!(0) 讚! | asdgh |
作者: Yves Morton 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2018-09-26 08:18:18 評論於 Great magazine. Everyone should give it a try to submit!(0) 讚! | Yves Morton |
作者: 凌霄高洁 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2017-07-14 22:31:16 評論於 As long as we can keep the journal indexed by SCI, it will be fine. If the school starts using CiteScore for evaluation, there is nothing to worry about. On one hand, CiteScore includes a wider range of journals, so this journal will definitely be included. Additionally, it benefits smaller journals as well, so everyone will have a fairer chance. I hope the school adopts CiteScore(0) 讚! | 凌霄高洁 |
首頁 上一頁 1 下一頁 末頁 (頁 |
Contact us